Conference Program (PDF) - ISOQOL

Friday
Graeme Hawthorne, Psychiatry, The University of Melbourne, Alain LePlege, Département d’Histoire et de Philosophie des
Science, University of Paris
Individual Abstract 1039
THE WHOQOL-PAIN: DERIVATION OF AN INSTRUMENT TO ASSESS QUALITY OF LIFE IN PEOPLE WITH CHRONIC PAIN
Victoria L. Mason, Psychological Sciences, University of Worcester, Worcester, UK, Suzanne M. Skevington, Department of
Psychology, University of Bath, Bath, UK
3:30 – 3:45 pm
Break
West Wing Lobby
3:45 – 5:15 pm
Concurrent Oral Sessions
Responsiveness II
Chair: Josephine Norquist, MSc
Sandringham Suite
1772/Clinically Significant Effect Sizes for Survival and Response Endpoints using the ½ Standard Deviation
Rule
Jeff Sloan, Paul Novotny, Daniel J. Sargent, Paul Decker, Rui Qin, Health Sciences Research, Mayo Clinic, Rochester, MN
1507/Relative responsiveness and statistical efficiency of QLQ-C30 v FACT-G
Madeleine King, Melanie Bell, Daniel Costa, Phyllis Butow, Psycho-Oncology Cooperative Research Group (PoCoG), University of
Sydney, Sydney, NSW, Australia, Byeongsang Oh, Medicine, Concord Repatriation General Hospital, Sydney, NSW, Australia
1148/Agreement About Identifying Patients Who Change Over Time: Cautionary Results in Cataract and Heart
Failure Patients
David Feeny, Center for Health Research, Kaiser Permanente, Portland, OR, Karen Spritzer, Ron D. Hays, Honghu Liu, Medicine,
UCLA, Los Angeles, CA, Theodore Ganiats, Family and Preventive Medicine, UC San Diego, La Jolla, CA, Robert M. Kaplan, Health
Services, UCLA, Los Angeles, CA, Mari Palta, Population Health Sciences, University of Wisconsin, Madison, WI, Dennis Fryback,
Population Health Sciences, University of Wisconsin, Huntington Beach, CA
1725/Effect sizes can be misleading: Is it time to change the way we measure change?
Jeremy C. Hobart, Clinical Neurology Research Group, Peninsula Medical School, Plymouth, Devon, UK, Stefan J. Cano, Clinical
Neurology Research Group, Peninsula Medical School, Plymouth, Devon, United Kingdom
Economic Evaluation II
Chair: Paul Kind, PhD
Sovereign Suite
1186/Relationships Between EQ-5D and FACT Scores in Patients with Esophageal or Gastric Cancer
David K. Ingledew, Psychology, Bangor University, Bangor, Gwynedd, UK, Rhiannon Whitaker, N Wales Organisation for
Randomised Trials in Health, Bangor University, Bangor, Gwynedd, United Kingdom, Ian T. Russell, Medicine, Swansea University,
Swansea, Glamorgan, United Kingdom, Daphne Russell, N Wales Organisation for Randomised Trials in Health, Bangor
University, Bangor, Gwynedd, United Kingdom
1069/Assessing Health-related Quality of Life (HRQL) in Lung Transplant Recipients using the Health Utility
Index Mark 3 (HUI3)
Maria Jose Santana, Lung transplant program, University of Alberta, Edmonton, AB, Canada, David Feeny, Center for Health
Research, Kaiser Permanente Northwest, Portland, Oregon, Sunita Ghosh, Experimental Oncology, Cross Cancer Institute,
Edmonton, Alberta, Canada, Roland G. Nador, Justin Weinkauf, Kathleen Jackson, Dale C. Lien, Lung transplant program,
University of Aberta Hospital, Edmonton, AB, Canada
1737/Health gain for a controversial operation on appropriately selected cases: VTs in childhood OME
Mark P. Haggard, Helen Spencer, Experimental Psychology, University of Cambridge, Cambridge, UK, Sarah C. Smith, Health
Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK
1568/Using QALYs to assess changes in the impact of chronic conditions on population HRQL
Oriol Cunillera, Health Services Research Unit, IMIM-Institut de Recerca Hospital del Mar, Barcelona, Spain, Spain, Michael
Herdman, Health Services Research Unit, CIBERESP, IMIM-Institut de Recerca Hospital del Mar, Barcelona, Spain, Spain, Ridard
Tresserras, Direcció General de Planificació i Avaluació, Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain,
Spain, Luis Rajmil, Barcelona, Spain, Spain, Gemma Vilagut, Health Services Research Unit, CIBERESP, IMIM-Institut de Recerca
28